EDGAR Filing Documents for 0001178913-23-002694

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001178913-23-002694

Filing Date

2023-08-04

Accepted

2023-08-04 16:05:53

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	zk2330099.htm	F-3	371584
2	EXHIBIT 5.1	exhibit_5-1.htm	EX-5.1	8925
3	EXHIBIT 5.2	exhibit_5-2.htm	EX-5.2	9271
4	EXHIBIT 23.1	exhibit_23-1.htm	EX-23.1	3418
5	FILING FEES TABLE	exhibit_107.htm	EX-FILING FEES	30380
6		image0.jpg	GRAPHIC	180746
7		image00001.jpg	GRAPHIC	2390
8		image00002.jpg	GRAPHIC	22929
9		image00003.jpg	GRAPHIC	12196
	Complete submission text file	0001178913-23-002694.txt		725485

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739

Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131

RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: F-3 | Act: 33 | File No.: 333-273709 | Film No.: 231144001
SIC: 2834 Pharmaceutical Preparations